XML 90 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
Marketable Securities
12 Months Ended
Dec. 31, 2014
Cash, Cash Equivalents, and Investments [Abstract]  
Cash, Cash Equivalents and Investments

3 Marketable Securities

 

The Company's marketable securities within cash equivalents and investments included in the consolidated balance sheets are detailed as follows (in thousands):

   December 31, 2014
   Amortized Unrealized Unrealized Fair
   Cost Gain Loss Value
U.S. Treasury securities $ 626,683 $ 246 $ (157) $ 626,772
Foreign government securities   24,998   -   -   24,998
Corporate debt securities   984,668   125   (688)   984,105
Time deposits   64,240   -   -   64,240
Equity securities   77   70   -   147
 Total $ 1,700,666 $ 441 $ (845) $ 1,700,262
              
Amounts included in:            
 Cash equivalents $ 67,051 $ - $ - $ 67,051
 Investments   1,633,615   441   (845)   1,633,211
 Total $ 1,700,666 $ 441 $ (845) $ 1,700,262

   December 31, 2013
   Amortized Unrealized Unrealized Fair
   Cost Gain Loss Value
U.S. Treasury securities $ 556,438 $ 111 $ (10) $ 556,539
Foreign government securities   139,670   -   -   139,670
Corporate debt securities   629,477   190   (233)   629,434
Time deposits   74,050   -   -   74,050
Equity securities   77   70   -   147
 Total $ 1,399,712 $ 371 $ (243) $ 1,399,840
              
Amounts included in:            
 Cash equivalents $ 36,966 $ - $ - $ 36,966
 Investments   1,362,746   371   (243)   1,362,874
 Total $ 1,399,712 $ 371 $ (243) $ 1,399,840

The estimated fair value of marketable debt securities by maturity date is as follows (in thousands):

   December 31, 2014 December 31, 2013
Due in one year or less $872,872 $1,011,459
Due after one year through three years  763,003  314,184
 Total $1,635,875 $1,325,643

In the year ended December 31, 2013, the Company recorded a $2 million charge for an other-than-temporary impairment to an investment. Realized gains and losses on sales of investments were not material in 2014, 2013 and 2012.